KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Cash & Current Investments (2016 - 2025)

Historic Cash & Current Investments for Novavax (NVAX) over the last 17 years, with Q3 2025 value amounting to $762.9 million.

  • Novavax's Cash & Current Investments fell 1611.91% to $762.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $762.9 million, marking a year-over-year decrease of 1611.91%. This contributed to the annual value of $923.1 million for FY2024, which is 6237.64% up from last year.
  • Latest data reveals that Novavax reported Cash & Current Investments of $762.9 million as of Q3 2025, which was down 1611.91% from $612.3 million recorded in Q2 2025.
  • Over the past 5 years, Novavax's Cash & Current Investments peaked at $2.1 billion during Q2 2021, and registered a low of $480.6 million during Q1 2024.
  • Moreover, its 5-year median value for Cash & Current Investments was $923.1 million (2024), whereas its average is $1.1 billion.
  • Its Cash & Current Investments has fluctuated over the past 5 years, first skyrocketed by 74166.42% in 2021, then crashed by 6322.21% in 2023.
  • Quarter analysis of 5 years shows Novavax's Cash & Current Investments stood at $1.5 billion in 2021, then decreased by 11.76% to $1.3 billion in 2022, then plummeted by 57.48% to $568.5 million in 2023, then surged by 62.38% to $923.1 million in 2024, then dropped by 17.35% to $762.9 million in 2025.
  • Its Cash & Current Investments was $762.9 million in Q3 2025, compared to $612.3 million in Q2 2025 and $731.5 million in Q1 2025.